Dihexa

What it is

Dihexa is the one people try when they want memory and learning sharper, not just focus: it was built to make brain cells form new connections, and in animals it did that at doses far below anything else. What it does in a human is unknown, because nobody has tested it, and the pathway it works through is one that tumours also use.

The people drawn to it are those who feel their memory and learning have slipped, often older or post-concussion, and who have already tried Semax or Selank and want something that works on the wiring rather than the alertness. It is swallowed, not injected, which makes it easy to run. It is the wrong choice as a first nootropic, for anyone who has had cancer, and for anyone who wants a product with a safety record; this is as experimental as the catalog gets.

Reports from people who run it are mixed and slow. The ones who notice something describe easier recall and faster learning building over two to four weeks, not a same-day effect like Semax. A fair number notice nothing. There is no 'feel' to chase, which is exactly why people make the mistake of doubling the dose in week one. If nothing has changed by week six at 10 mg, more will not help.

Our doses are 5 mg to start, 10 mg standard, 20 mg at most, once a day by mouth, for 4 to 8 weeks, then at least 4 weeks off. The break is about caution, not tolerance: it caps how long you keep a tumour-linked growth pathway switched on, so keep runs short and breaks real. Note the units: milligrams, not micrograms, which is unusual for a peptide-like compound. It does not dissolve in water, so it comes as capsules or as a powder you take in oil or under the tongue; follow the vendor's instructions, since there is no standard preparation. Buy from somewhere with a certificate of analysis; a white powder with no verification is the usual way to pay for nothing. A 25 mg vial is less than a week at 5 mg, so price it per month before you start.

The evidence is animal only, and some of it is damaged. In rats it reversed memory deficits and drove new synapse formation at very low doses, which is the headline that made it famous. But there are no human studies of any size, three of the lab's papers on the HGF/c-Met mechanism have been retracted and the 2013 paper that introduced Dihexa carries an expression of concern, and the company that came out of the research (Athira, formerly M3 Biotechnology) dropped Dihexa for a related compound, fosgonimeton. The mechanism itself, HGF/c-Met, is a growth and cell-movement pathway that cancers exploit; switching it on for weeks is a theoretical risk nobody has measured.

If you want sharper focus today, Semax does that with decades of human use behind it. If you want calm plus focus, Selank. If you want a broad brain-repair compound with real human trials, Cerebrolysin has them. Dihexa is for people who have read all of that and still want to try the potent, unproven thing, in short runs, with a clear stop date, and with no cancer anywhere in their history.

What people use it for

Safety, in brief

The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.

Sources

The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.

1. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agentsMcCoy et al., J Pharmacol Exp Ther 2013 · Study
2. AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling PathwaySun et al., Brain Sci 2021 · Study
3. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseasesWright et al., Prog Neurobiol 2015 · Review